Syndax Pharmaceuticals (SNDX) Total Debt (2020 - 2024)
Syndax Pharmaceuticals (SNDX) posted quarterly Total Debt of $343.7 million for Q4 2024, up 1600.89% quarter-over-quarter from $20.2 million in Q2 2022.
Syndax Pharmaceuticals (SNDX) Total Debt (2020 - 2024) Analysis & Trends
Syndax Pharmaceuticals' Total Debt history runs 4 years deep, the most recent figure standing at $343.7 million for Q4 2024.
- In Q4 2024, Total Debt changed N/A year-over-year to $343.7 million; the TTM figure through Dec 2024 stood at $343.7 million (changed N/A YoY), while the FY2024 annual figure was $343.7 million, changed N/A from the prior year.
- Total Debt for Q4 2024 stood at $343.7 million, up from $20.2 million in the prior quarter.
- The five-year high for Total Debt was $343.7 million in Q4 2024, with the low at $19.8 million in Q1 2020.
- The 4-year median for Total Debt is $20.1 million (2020), against an average of $49.5 million.
- Peak annual rise in Total Debt reached 2.36% in 2021, while the deepest fall reached 1.11% in 2021.
- Syndax Pharmaceuticals' Total Debt stood at $20.1 million in 2020, then retreated by 1.11% to $19.9 million in 2021, then increased by 1.56% to $20.2 million in 2022, then jumped by 1600.89% to $343.7 million in 2024.
- Business Quant data shows SNDX's Total Debt at $343.7 million in Q4 2024, $20.2 million in Q2 2022, and $20.0 million in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.07 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 9.34 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 546.77 Mn |
| 10 | Syndax Pharmaceuticals | 1.77 Bn | 1.22 Bn | 60.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 343.68 Mn |
| Jun 30, 2022 | 20.21 Mn |
| Mar 31, 2022 | 20.05 Mn |
| Dec 31, 2021 | 19.90 Mn |
| Sep 30, 2021 | 20.48 Mn |
| Jun 30, 2021 | 20.35 Mn |
| Mar 31, 2021 | 20.23 Mn |
| Dec 31, 2020 | 20.12 Mn |
| Sep 30, 2020 | 20.01 Mn |
| Jun 30, 2020 | 19.90 Mn |
| Mar 31, 2020 | 19.79 Mn |